Biosig Technologies Inc
NASDAQ:BSGM
Biosig Technologies Inc
NASDAQ:BSGM
Price:
1.7 USD
-4.49%
Market Closed
Updated:
May 4, 2024
Section:
Relative Value
The Relative Value of one
BSGM
stock under the Base Case scenario is
0.01
USD.
Compared to the current market price of 1.7 USD,
Biosig Technologies Inc
is
Overvalued by 99%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BSGM
Relative Value
Base Case
0.01
USD
Overvaluation 99%
Valuation Multiples
Multiples Across Competitors
BSGM Competitors Multiples
Biosig Technologies Inc Competitors
Biosig Technologies Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Biosig Technologies Inc
NASDAQ:BSGM
|
15.4m USD | 853.8 | -0.5 | -0.5 | -0.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
183.5B USD | 4.6 | 32.6 | 19.2 | 28.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
135.1B USD | 18.5 | 68 | 55.8 | 69.9 | |
| US |
|
Stryker Corp
NYSE:SYK
|
124.8B USD | 6 | 37.1 | 24.1 | 29.7 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
108.5B USD | 3.4 | 25.8 | 13.8 | 19.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.2B USD | 7.2 | 60.2 | 30.7 | 45.3 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.7B USD | 3.5 | 55.6 | 18.6 | 39.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
57.9B EUR | 2.7 | 38.1 | 18.3 | 30.9 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
51.6B USD | 8.4 | 36.5 | 26.5 | 28.7 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
50.9B USD | 13.4 | 79.6 | 59.5 | 77.4 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 10.7 | 32.5 | 28.3 | 28.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
